Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace - 1 Mar 2009

Santus P, Casanova F, Biondi M L, Blasi F, Di Marco F, Centanni S

Abstract excerpt

BACKGROUND: Chronic obstructive lung disease (COPD) is characterised by partially reversible usually progressive airflow limitation caused by inflammation and remodelling. Stromelysin-1 (MMP-3) has regulatory activity on other matrix-metalloproteinases. Altered MMP-3 activity has been described in different diseases. We investigated the role of a promoter MMP-3 polymorphism in determining susceptibility and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Disease Progression

Share to Matrix Metalloproteinase 3

Share to Promoter Regions, Genetic

Share to Pulmonary Disease, Chronic Obstructive

Share to Risk Factors

Source

Identifiers

PMID: 19522160
DOI: 10.4081/monaldi.2009.371

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.PMID 19522160Read ↗

MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.Semantic proximity Read ↗

Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival.Semantic proximity Read ↗

Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.Semantic proximity Read ↗

ADAM33 gene polymorphisms in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population.Semantic proximity Read ↗

Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.Semantic proximity Read ↗

Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.Semantic proximity Read ↗

Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.Semantic proximity Read ↗

The role of matrix metalloproteinase polymorphisms in the rate of decline in lung functionSemantic proximity Read ↗

Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.Semantic proximity Read ↗

Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: Association with severity and progression of rheumatoid arthritis in a prospective study.Semantic proximity Read ↗

Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.